The influence of various sample storage conditions and sample microbial contamination on concentrations of routine biochemical parameters

  • Tamara Gojkovic Department of Medical Biochemistry, University of Belgrade - Faculty of Pharmacy, Serbia
  • Sandra Vladimirov Department of Medical Biochemistry, University of Belgrade - Faculty of Pharmacy, Serbia
  • Tamara Antonic Department of Medical Biochemistry, University of Belgrade - Faculty of Pharmacy, Serbia
  • Natasa Bogavac-Stanojevic Department of Medical Biochemistry, University of Belgrade - Faculty of Pharmacy, Serbia
  • Katarina Novovic Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia
  • Vesna Spasojevic-Kalimanovska Department of Medical Biochemistry, University of Belgrade - Faculty of Pharmacy, Serbia
  • Brankica Filipic Department of Microbiology and Immunology, University of Belgrade - Faculty of Pharmacy, Serbia
DOI: https://doi.org/10.5937/jomb0-40360
Keywords: freeze-thaw cycles, microbiological cross-contamination, preservative potassium-fluoride, preanalytical phase

Abstract


Background: The pre-analytical (PA) phase is the most vulnerable phase of laboratory testing procedure, with critical procedures-collection, handling, sample transport, and time and temperature of sample storage. The aim of this study was to examine if different anticoagulants, storage conditions, and freeze-thaw cycles (FTCs) influence the concentrations of basic biochemical parameters. In parallel, the presence and the effect of sample microbiological contamination during routine laboratory work were examined.

Methods: Two plasma pools (EDTA, and sodium-fluoride/potassium oxalate plasma (NaF)) were stored at +4C˚/-20˚C. Total cholesterol (TC), glucose, triglycerides (TG), urea, total protein (TP), and albumin concentrations were measured using Ilab 300+. Sample microbiological contamination was determined by 16S rRNA sequence analysis. The experiment encompassed a 5 day-period: Day 1–fresh sample, Day 2–1st FTC, Day 3–2nd FTC, Day 4–3rd FTC, Day 5–4th FTC. The appearance of bacteria in two consecutive samples was the experiment's endpoint.

Results: During 4 FTCs there were no changes in plasma urea concentrations. Glucose was stable in EDTA+4˚C and NaF- 20˚C until the 3rd FTC (P=0.008, P=0.042, respectively). Changes in protein concentrations followed the zig-zag pattern. TG concentrations changed significantly in the EDTA-20˚C sample after 1st and 4th FTCs (P=0.022, P=0.010, respectively). In NaF samples no contamination was observed during 4 FTCs.

 

Conclusions: Urea and glucose concentrations were robust. Changes in lipid and protein concentrations after FTCs follow complex patterns. Bacterial growth was not observed in NaF plasma samples. This can promote NaF use in analytical procedures in which microbiological contamination affects the quality of analysis.

References

1. Simundic AM, Lippi G. Preanalytical phase–a continuous challenge for laboratory professionals. Biochem Med (Zagreb). 2012; 22(2):145-9. doi: 10.11613/bm.2012.017
2. Cornes M, van Dongen-Lases E, Grankvist K, Ibarz M, Kristensen G, Lippi G, Nybo M, Simundic AM. Order of blood draw: opinion paper by the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE). Clin Chem Lab Med. 2017; 55(1):27-31. doi:10.1515/cclm-2016-0426
3. Monneret D, Godmer A, Le Guen R, Bravetti C, Emeraud C, Marteau A, Alkouri R, Mestari F, Dever S, Imbert-Bismut F, Bonnefont-Rousselot D. Stability of routine biochemical analytes in whole blood and plasma from lithium heparin gel tubes during 6-hr storage. J Clin Lab Anal. 2016; 30(5):602-9. doi: 10.1002/jcla.21909.
4. Plebani M. Errors in clinical laboratories or errors in laboratory medicine?. Clin Chem Lab Med. 2006; 44(6):750-9. doi: 10.1515/CCLM.2006.123.
5. Sikaris KA. Enhancing the clinical value of medical laboratory testing. Clin Biochem Rev. 2017; 38(3):107-114.
6. Lippi G, Banfi G, Church S, Cornes M, De Carli G, Grankvist K, Kristensen GB, Ibarz M, Panteghini M, Plebani M, Nybo M. Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE). Clin Chem Lab Med. 2015; 53(3):357-70. doi: 10.1515/cclm-2014-1051.
7. Lippi G, Guidi GC. Risk management in the preanalytical phase of laboratory testing. Clin Chem Lab Med. 2007; 45(6):720-7. doi: 10.1515/CCLM.2007.167.
8. Inal TC, Goruroglu Ozturk O, Kibar F, Cetiner S, Matyar S, Daglioglu G, Yaman A. Lean six sigma methodologies improve clinical laboratory efficiency and reduce turnaround times. J Clin Lab Anal. 2018;32(1):e22180.
9. Flores CF, Pineda ÁD, Bonilla VM, Sáenz-Flor K. Sample management: stability of plasma and serum on different storage conditions. EJIFCC. 2020; 31(1):46-55.
10. Eliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37(2):234-44. doi: 10.1093/ije/dym276.
11. Rocca JD, Simonin M, Blaszczak JR, Ernakovich JG, Gibbons SM, Midani FS, Washburne AD. The microbiome stress project: toward a global meta-analysis of environmental stressors and their effects on microbial communities. Front Microbiol. 2019; 9:3272. doi:10.3389/fmicb.2018.03272.
12. Weiss S, Amir A, Hyde ER, Metcalf JL, Song SJ, Knight R. Tracking down the sources of experimental contamination in microbiome studies. Genome Biol. 2014; 15(12):564. doi: 10.1186/s13059-014-0564-2.
13. Niederstebruch N, Sixt D, Benda BI, Banboye N. A suitable blood agar containing human blood especially for the use in laboratories of developing countries. J Infect Dev Ctries. 2017; 11(5):399-406. doi: 10.3855/jidc.8957.
14. Cuhadar S, Koseoglu M, Atay A, Dirican A. The effect of storage time and freeze-thaw cycles on the stability of serum samples. Biochem Med (Zagreb). 2013; 23(1):70-7. doi: 10.11613/bm.2013.009.
15. Lippi G, Becan-McBride K, Behúlová D, Bowen RA, Church S, Delanghe J, Grankvist K, Kitchen S, Nybo M, Nauck M, Nikolac N. Preanalytical quality improvement: in quality we trust. Clin Chem Lab Med. 2013;51(1):229-41. doi: 10.1515/cclm-2012-0597.
16. Gojkovic T, Vladimirov S, Spasojevic-Kalimanovska V, Zeljkovic A, Vekic J, Arsenijevic J, Djuricic I, Sobajic S, Jelic-Ivanovic Z. Preanalytical and analytical challenges in gas chromatographic determination of cholesterol synthesis and absorption markers. Clin Chim Acta. 2018; 478:74-81. doi: 10.1016/j.cca.2017.12.032.
17. Chen D, Han W, Huan T, Li L, Li L. Effects of Freeze–Thaw Cycles of Blood Samples on High-Coverage Quantitative Metabolomics. Anal Chem. 2020; 92(13):9265-9272. doi: 10.1021/acs.analchem.0c01610.
18. Gislefoss RE, Lauritzen M, Langseth H, Mørkrid L. Effect of multiple freeze-thaw cycles on selected biochemical serum components. Clin Chem Lab Med. 2017;55(7):967-973. doi: 10.1515/cclm-2016-0892.
19. Liu Y, Liu Y, Du Z, Zhang L, Chen J, Shen Z, Liu Q, Qin J, Lv H, Wang H, He L. Skin microbiota analysis-inspired development of novel anti-infectives. Microbiome. 2020;8(1):85. doi: 10.1186/s40168-020-00866-1.
20. Vandecandelaere I, Van Nieuwerburgh F, Deforce D, Coenye T. Metabolic activity, urease production, antibiotic resistance and virulence in dual species biofilms of Staphylococcus epidermidis and Staphylococcus aureus. PLoS One. ;12(3):e0172700. doi: 10.1371/journal.pone.0172700. eCollection 2017.
21. Srinivasan M, Schimmel M, Riesen M, Ilgner A, Wicht MJ, Warncke M, Ellwood RP, Nitschke I, Müller F, Noack MJ. High‐fluoride toothpaste: a multicenter randomized controlled trial in adults. Community dentistry and oral epidemiology. 2014;42(4):333-40. doi: 10.1016/j.jdent.2013.12.012.
22. Baudet A, Guillaso M, Grimmer L, Mediqai Study Group, Regad M, Florentin A. Microbiological Contamination of the Office Environment in Dental and Medical Practice. Antibiotics (Basel). 2021;10(11):1375. doi: 10.3390/antibiotics10111375.
23. Lu B, Hu Y, Huang W, Wang M, Jiang Y, Lou T. Effect of transition metal ions on the B ring oxidation of sterols and their kinetics in oil-in-water emulsions. Sci Rep. 2016;6:27240. doi: 10.1038/srep27240.
24. Zivkovic AM, Wiest MM, Nguyen UT, Davis R, Watkins SM, German JB. Effects of sample handling and storage on quantitative lipid analysis in human serum. Metabolomics. 2009 ;5(4):507-516. doi: 10.1007/s11306-009-0174-2.
25. Lai PS, Allen JG, Hutchinson DS, Ajami NJ, Petrosino JF, Winters T, Hug C, Wartenberg GR, Vallarino J, Christiani DC. Impact of environmental microbiota on human microbiota of workers in academic mouse research facilities: An observational study. PLoS One. 2017;12(7):e0180969.
26. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Turner P, Parkhill J, Loman NJ, Walker AW. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014;12:87. doi: 10.1186/s12915-014-0087-z.
27. Van den Berg SA, Thelen MH, Salden LP, Van Thiel SW, Boonen KJ. It takes acid, rather than ice, to freeze glucose. Sci Rep. 2015;5:8875. doi: 10.1038/srep08875.
28. Flood A, Pfeiff er R, Mai V, Remaley A, Lanza E, Schatzkin A. The effects of freeze-thaw cycles on serum measurement of insulin and glucose in epidemiologic studies. [abstract] Annals of Epidemiol 2002;12:528. doi:10.1016/S1047- 2797(02)00391-5
29. Paskal W, Paskal AM, Dębski T, Gryziak M, Jaworowski J. Aspects of modern biobank activity–comprehensive review. Pathol Oncol Res. 2018;24(4):771-785. doi: 10.1007/s12253-018-0418-4.
30. Harati MD, Williams RR, Movassaghi M, Hojat A, Lucey GM, Yong WH. An introduction to starting a biobank. Methods Mol Biol. 2019;1897:7-16. doi: 10.1007/978-1-4939-8935-5_2.
Published
2023/12/25
Issue
Ahead of print
Section
Original paper

Copyright (c) 2023 Tamara Gojkovic, Sandra Vladimirov, Tamara Antonic, Natasa Bogavac-Stanojevic, Katarina Novovic, Vesna Spasojevic-Kalimanovska, Brankica Filipic

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.